Overworked businessman sitting in office, sleeping in front of laptop Obesity, night eating, parasomnia, sleep talking and drunkenness, and ADHD symptoms are more frequent in children than adults at ...

HELSINKI/LONDON, May 23 (Reuters) - GlaxoSmithKline Plc's H1N1 pandemic flu shot may put adults at higher risk of developing narcolepsy, not only children as previous studies found, Finland's National ...

Evidence linking GlaxoSmithKline's ($GSK) swine flu vaccine Pandemrix to heightened risk of narcolepsy has emerged piecemeal over the past few years. It began in 2011 ...

With this new indication, pitolisant is now approved to treat excessive daytime sleepiness, cataplexy, or both, in patients aged 6 years or older with narcolepsy.

Please provide your email address to receive an email when new articles are posted on . Macfadden and colleagues sought to assess the safety, efficacy, tolerability, sleep quality and preferences of ...

WAKIX is the first and only non-scheduled treatment approved for excessive daytime sleepiness or cataplexy in adult patients with narcolepsy PLYMOUTH MEETING, Pa. and CHICAGO, Oct. 14, 2020 ...

Solriamfetol is a dopamine and norepinephrine reuptake inhibitor that shares some of the properties of current ADHD medications. Researchers conducted a randomized, double-blind, placebo-controlled, ...

The company said Tuesday that the FDA greenlit a supplemental new drug application for Wakix, a treatment for cataplexy, a narcolepsy symptom characterized by sudden muscle weakness, in pediatric ...

First presentation of the Phase 4 XYLO switch study reports blood pressure reductions in patients with narcolepsy when switching from twice-nightly high- to low-sodium oxybate Novel intermediate ...